Compugen Ltd.(TEL Aviv Stock Exchange : CGEN)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-8.81%||11.69||0.7%||$817.17m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.34%||188.34||1.9%||$535.92m|
|GILD||Gilead Sciences, Inc.||-0.68%||66.90||1.0%||$494.68m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.31%||532.60||2.7%||$387.20m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.71%||179.38||2.0%||$337.51m|
|TXG||10X Genomics, Inc.||0.02%||197.91||0.0%||$177.37m|
|EXAS||EXACT Sciences Corp.||0.37%||128.13||18.1%||$177.05m|
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.